BIAF: bioAffinity Technologies, Inc. Common Stock Company Profile & Statistics

About

bioAffinity Technologies Inc. is a cancer diagnostics company which develops noninvasive, early-stage diagnostics to detect cancer and diseases of the lung and is researching targeted therapies to treat cancer. bioAffinity Technologies Inc. is based in SAN ANTONIO.

Info & Links

CEO

Maria Zannes

Headquarters

22211 WEST INTERSTATE-10, SUITE 1206
SAN ANTONIO, TX 78257, UNITED STATES

Auditor

WithumSmith+Brown, PC

Share holders

Employees

bioAffinity Technologies, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization²

12.39M

Enterprise Value

12.85M

Enterprise Value/EBITDA(ttm)

-1.66

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

1.35

Price to Book(mrq)

3.49

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

34.85%

Operating Margin(ttm)

-91.22%

Profit Margin(ttm)

-90.47%

Return on Equity(ttm)

-205.09%

Return on Invested Capital(ttm)

-180.08%

Return on Assets(ttm)

-115.95%

Income Statement

Revenue(ttm)

9.37M

Revenue Per Share(ttm)

0.60

Gross Profit(ttm)

3.28M

EBITDA(ttm)³

-7.75M

Net Income Available to Common(ttm)

-8.45M

Diluted EPS(ttm)

-0.82

Share Statistics

Beta (5Y Monthly)

2.95

52-Week Change

-42.96%

S&P 500 52-Week Change

18.16%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

15.58M

Dividend Yield

0.00%

Float⁴

10.11M

% Held by Insiders

35.12%

% Held by Institutions

1.64%

Balance Sheet

Total Cash(mrq)

756.60K

Total Cash Per Share(mrq)

0.05

Total Debt(mrq)

1.22M

Total Debt/Equity(mrq)

39.08%

Current Ratio(mrq)

1.02%

Quick Ratio(mrq)

1.01%

Book Value Per Share(mrq)

0.23

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.45

Free Cash Flow(ytd)

-5.67M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

BIAF

bioAffinity Technologies, Inc. Common Stock

bioAffinity Technologies, Inc. Common Stock Profile